116 related articles for article (PubMed ID: 32956285)
1. Detection of Recurrent Hepatitis C Viremia Using Surveillance Data, New York City.
Guerra K; Bocour A; Moore MS; Winters A
J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):126-129. PubMed ID: 32956285
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Surveillance-Based Algorithms to Estimate Hepatitis C Treatment and Cure in New York City.
Moore MS; Bocour A; Jordan L; McGibbon E; Varma JK; Winters A; Laraque F
J Public Health Manag Pract; 2018; 24(6):526-532. PubMed ID: 29227418
[TBL] [Abstract][Full Text] [Related]
3. A Surveillance-Based Hepatitis C Care Cascade, New York City, 2017.
Moore MS; Bocour A; Laraque F; Winters A
Public Health Rep; 2018; 133(4):497-501. PubMed ID: 29902392
[TBL] [Abstract][Full Text] [Related]
4. Assessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis.
Türkoğlu E; Parlak Z; Barut HŞ
Turk J Med Sci; 2022 Dec; 52(6):1984-1990. PubMed ID: 36945985
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
European Union HCV Collaborators
Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
[TBL] [Abstract][Full Text] [Related]
6. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
7. Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies.
Sarrazin C; Isakov V; Svarovskaia ES; Hedskog C; Martin R; Chodavarapu K; Brainard DM; Miller MD; Mo H; Molina JM; Sulkowski MS
Clin Infect Dis; 2017 Jan; 64(1):44-52. PubMed ID: 27737953
[TBL] [Abstract][Full Text] [Related]
8. Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations.
Ford MM; Jordan AE; Johnson N; Rude E; Laraque F; Varma JK; Hagan H
J Public Health Manag Pract; 2018; 24(1):41-48. PubMed ID: 28141668
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a hepatitis C clinical care coordination programme's effect on treatment initiation and cure: A surveillance-based propensity score matching approach.
Deming R; Ford MM; Moore MS; Lim S; Perumalswami P; Weiss J; Wyatt B; Shukla S; Litwin A; Reynoso S; Laraque F
J Viral Hepat; 2018 Nov; 25(11):1236-1243. PubMed ID: 29757491
[TBL] [Abstract][Full Text] [Related]
10. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.
Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV;
Lancet Public Health; 2023 Apr; 8(4):e294-e304. PubMed ID: 36965984
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents.
Chen Q; Ayer T; Adee MG; Wang X; Kanwal F; Chhatwal J
JAMA Netw Open; 2020 Nov; 3(11):e2021173. PubMed ID: 33206188
[TBL] [Abstract][Full Text] [Related]
13. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
14. Estimating the prevalence of chronic hepatitis C virus infection in New York City, 2015.
Bocour A; Greene SK; Laraque F; Winters A
Epidemiol Infect; 2018 Sep; 146(12):1537-1542. PubMed ID: 29932040
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community.
Perumalswami PV; DeWolfe Miller F; Orabee H; Regab A; Adams M; Kapelusznik L; Aljibawi F; Pagano W; Tong V; Dieterich DT
Liver Int; 2014 Feb; 34(2):253-8. PubMed ID: 23890188
[TBL] [Abstract][Full Text] [Related]
16. The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis.
Huang P; Wang Y; Yue M; Ge Z; Xia X; Jeyarajan AJ; Holmes JA; Yu R; Zhu C; Yang S; Lin W; Chung RT
Liver Int; 2021 Oct; 41(10):2341-2357. PubMed ID: 34051040
[TBL] [Abstract][Full Text] [Related]
17. HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.
Prussing C; Chan C; Pinchoff J; Kersanske L; Bornschlegel K; Balter S; Drobnik A; Fuld J
Epidemiol Infect; 2015 May; 143(7):1408-16. PubMed ID: 25170631
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Clearance After Relapse Following Direct-Acting Antiviral Treatment for Chronic HCV Infection.
Kuriry H; Casey J; Krassenburg L; La D; Kuczynski M; Shah H; Janssen HLA; Hansen BE; Feld JJ
Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2398-2406.e1. PubMed ID: 32629131
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C microelimination among people living with HIV in Taiwan.
Chen GJ; Ho SY; Su LH; Chang SY; Hsieh SM; Sheng WH; Liu WD; Huang YS; Lin KY; Chen YT; Su YC; Liu WC; Sun HY; Hung CC
Emerg Microbes Infect; 2022 Dec; 11(1):1664-1671. PubMed ID: 35608049
[TBL] [Abstract][Full Text] [Related]
20. Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs.
Yeung A; Palmateer NE; Dillon JF; McDonald SA; Smith S; Barclay S; Hayes PC; Gunson RN; Templeton K; Goldberg DJ; Hickman M; Hutchinson SJ
J Hepatol; 2022 Mar; 76(3):549-557. PubMed ID: 34634387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
